Fireside Chat: A Vision for the Future: Moderna’s Plans for mRNA Technology, Manufacturing and Scale
  • Pivoting fearlessly: How Moderna transitioned from a pandemic to an endemic market
  • Building for scale: Where the company is investing and partnering as it plans to launch up to 15 products in 5 years
  • Prioritizing culture: What it took to encode the company’s mindsets and unique culture

Jerh Collins
Chief Technical Operations and Quality Officer

As Chief Technical Operations and Quality Officer, Dr. Collins is responsible for the technical development, quality, and supply of preclinical, clinical and commercial programs within Moderna’s portfolio.

Dr. Collins joined Moderna from Novartis, where he held roles of increasing responsibility over the last nearly 30 years, focused on pharmaceutical production and manufacturing, including roles serving as Head of Global Chemical Operations and Anti-Infectives and as Head of Global Chemical Operations.

Dr. Collins received his Bachelor of Science in Chemistry and his Ph.D. in Organic Chemistry from University College Cork, Ireland. He also conducted post-doctoral cancer research at Arizona State University.